Arca
Skip to content

Neuralink Corp.

5 private offerings reported to the SEC on Form D since 2016, $1.2B sold in all. Biotech, CA.

  • Form D offerings: 5
  • Reported sold: $1.2B
  • Newest: Jun 12, 2025

Every Form D Offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Jun 12, 2025$649.0M$649.0MNeuralink Corp.Biotech · CANot amended0001708503-25-000003
Aug 8, 2023$323.2M$323.2MNeuralink Corp.Biotech · CANov 22, 20230001708503-23-000001
Aug 4, 2021$205.9M$205.9MNeuralink Corp.Biotech · CANot amended0001708503-21-000002
May 10, 2019$39.3M$51.3MNeuralink Corp.Biotech · CANot amended0001708503-19-000001
Aug 25, 2017$27.0M$100.2MNeuralink Corp.Biotech · CANot amended0001708503-17-000001

SEC Profile

From the company's EDGAR record
Business address
Fremont, Ca
Incorporated in
NV
All SEC filings
CIK 1708503 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.